LONGMONT, CO 15 August 2012 – Acertara Acoustic Laboratories, the world’s only independent ISO/IEC 17025:2005 accredited medical ultrasound acoustic measurement and testing laboratory, announces that its recently introduced Artis™ TDS ultrasonic test device now provides users with a quantitative assessment of the receive sensitivity of ultrasound transducers used in the growing and exciting field of photoacoustic imaging.
Commenting on the Artis™ time delay spectrometry (TDS) device G. Wayne Moore President and CEO of Acertara, said: "Many researchers around the world feel strongly that the unique properties of photoacoustics will rapidly be adopted and accepted as an important tool in the earlier detection of various cancers, as well as other diagnostic uses. Photoacoustics combines the advantages of LASER stimulation of targets with ultrasound receive sensitivity and system processing providing both morphologic information as well as functional data. One very key issue in using this technology is to objectively establish a baseline of sensitivity performance of the ultrasound component of the probe and matching those sensitivity parameters to the intended clinical application to ensure an efficacious study."
Artis™ does this rapidly by using the TDS technique to objectively determine the receive sensitivity versus frequency of the probes. Once this result has been established for any given probe the physician can both match the proper probe to the clinical application and have the probe re-tested as a function of time to ensure continuing baseline performance levels.
"At Acertara we believe that new ultrasound technologies, or combination technologies, such as photoacoustic imaging need to have corresponding test technologies that ensure both the efficaciousness and safety of the clinical studies. To that end our R&D team is focused on creating these novel test technologies as evidenced by the Artis™ product."
The Artis™ device is commercially available and was introduced at the American Institute of Ultrasound in Medicine in 2012. Artis™ will also be on display in the Acertara booth at the IEEE Ultrasonics Symposium in Dresden, Germany in October of 2012.
About Acertara:
Acertara Acoustic Laboratories, located in Longmont, Colorado is an independent ISO/IEC 17025:2005 accredited advanced acoustic measurement and testing facility providing diagnostic and therapeutic acoustic power testing and measurement services to ultrasound OEMs, researchers, and regulatory bodies around the world. Acertara also manufactures and sells a complete line of acoustic power testing products; including its industry standard Acoustic Power Lab Suite and AMS software. Acertara also provides US FDA 510(k) submission services. Additionally, Acertara offers contract-based advanced ultrasound research and development services. Additional information for Acertara is available on its website at www.acertaralabs.com, or contact sales@acertaralabs.com. Acertara Acoustic Laboratories LLC is a Veteran owned and operated business.